BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $550,000 | +105.2% | 6,420 | +75.2% | 0.01% | -14.3% |
| Q2 2020 | $268,000 | -26.6% | 3,665 | -45.3% | 0.01% | -17.6% |
| Q4 2019 | $365,000 | -37.1% | 6,700 | -51.8% | 0.02% | -54.1% |
| Q3 2019 | $580,000 | +181.6% | 13,900 | +195.7% | 0.04% | +42.3% |
| Q2 2019 | $206,000 | – | 4,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |